Ileitis abolishes tolerogenic functions of the enterohepatic bile acid pool
Zhiping XiaoiD, Kôichi SudôiD, Amber Delmas EliasoniD, Jiabao LiuiD, Paola Munoz‐TelloiD, Henry D. DionneiD, Fiona NguyeniD, Alexander D. HondrosiD, 楊惠娟, B. JoNell Hamilton, Akshaya BalasubramanianiD, Courtney Lynn HegneriD, Gilian Jacobsen, Erin M. TonziiD, Ila K. Kaul, Shannon M. SoucyiD, Corey Allan SiegeliD, George A. O’TooleiD, Daniel SchultziD, Casey Todd WeaveriD, Alexander Rodriguez‐PalaciosiD, Fabio CominelliiD, Henry M. KrauseiD, Maria Teresa AbreuiD, Paul A. DawsoniD, , Mark S. SundrudiD
Abstract
Bile acids (BAs) regulate lipid uptake, epithelial integrity, and immune responses in the gut. Hepatocytes synthesize primary BAs, which microbiota metabolize into secondary metabolites. Together, these species form a composite pool that circulates enterohepatically between the liver and intestines. Here, we show that immunoregulatory outputs of the enterohepatic BA pools involve competition between multiple BA species for individual nuclear receptors and are dependent on intestinal health. In healthy mice, the primary BA, tauro {beta} muricholic acid (t{beta}MCA) antagonized ROR{gamma}t-mediated Th17 function in the presence of two secondary BAs (tDCA, tLCA) which activated ROR{gamma}t. Conversely, ileitis in Crohns disease patients and Tnf{delta}ARE mice depleted primary BAs by reducing the number and function of BA transporting enterocytes. In mice, ileitis driven t{beta}MCA depletion enhanced tDCA and tLCA mediated ROR{gamma}t activation and supported Th17 cell function. Replenishing t{beta}MCA in Tnf{delta}ARE mice reestablished BA dependent Th17 cell regulation. Thus, intra pool competition underpins BA immunoregulatory functions and reveals new opportunities for precision Crohns disease therapy.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bile acid metabolites control Th17 and Treg cell differentiation
- CAR/Nr1i3 directs T cell adaptation to bile acids in the small intestine
M. L. Chen, X. Huang, … M. S. Sundrud·bioRxiv·Jul 30, 2020
- A microbial derived bile acid acts as GPBAR1 agonist and RORγt inverse agonist and reverses inflammation in inflammatory bowel disease
Michele Biagioli, Cristina Di Giorgio, … Stefano Fiorucci·Biomedicine & PharmacotherapyPeer-reviewed·Dec 1, 2024
- A Bacterial Bile Acid Metabolite Modulates Treg Activity through the Nuclear Hormone Receptor NR4A1
- Human gut bacteria produce TH17-modulating bile acid metabolites
D. Paik, L. Yao, … A. S. Devlin·bioRxiv·Jan 8, 2021
- Cholestasis alters polarization and suppressor function of hepatic regulatory T cells.
Ramesh Kudira, Z. F. Yang, … Alexander Gerhard Miethke·bioRxiv·May 17, 2024